Similar articles

• The importance of growth hormone (GH) and GH secretagogues for bone mass and density.

  Svensson J. Svensson J. Curr Pharm Des. 2002;8(23):2023-32. doi: 10.2174/1381612023393413. Curr Pharm Des. 2002. PMID: 12171516 Review.
• The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.

  Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG. Beshyah SA, et al. Clin Endocrinol (Oxf). 1994 Mar;40(3):383-91. doi: 10.1111/j.1365-2265.1994.tb03936.x. Clin Endocrinol (Oxf). 1994. PMID: 8187303 Clinical Trial.
• Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.

  Götherström G, Bengtsson BA, Bosaeus I, Johannsson G, Svensson J. Götherström G, et al. Eur J Endocrinol. 2007 Jan;156(1):55-64. doi: 10.1530/eje.1.02317. Eur J Endocrinol. 2007. PMID: 17218726
• The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults.

  Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG. Beshyah SA, et al. Clin Endocrinol (Oxf). 1995 Mar;42(3):249-54. doi: 10.1111/j.1365-2265.1995.tb01872.x. Clin Endocrinol (Oxf). 1995. PMID: 7758229 Clinical Trial.
• Growth hormone outgrows growth.

  Shalet SM. Shalet SM. Clin Endocrinol (Oxf). 2004 Jul;61(1):1-9. doi: 10.1111/j.1365-2265.2004.02012.x. Clin Endocrinol (Oxf). 2004. PMID: 15212638 Review. No abstract available.